Option Care Health (NASDAQ:OPCH) Upgraded at UBS Group

Option Care Health (NASDAQ:OPCH) was upgraded by analysts at UBS Group from a “neutral” rating to a “buy” rating in a report issued on Wednesday,Finviz reports. The brokerage currently has a $40.00 price target on the stock. UBS Group’s price target would indicate a potential upside of 30.34% from the company’s current price.

A number of other research firms have also weighed in on OPCH. Barrington Research restated an “outperform” rating and set a $38.00 target price on shares of Option Care Health in a research note on Monday, April 21st. JMP Securities reissued a “market outperform” rating and issued a $36.00 price objective on shares of Option Care Health in a research report on Tuesday, April 22nd. JPMorgan Chase & Co. lifted their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a research report on Thursday, March 6th. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and increased their target price for the company from $26.00 to $33.00 in a report on Monday, January 13th. Finally, Jefferies Financial Group raised Option Care Health from a “hold” rating to a “buy” rating and lifted their price target for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $35.50.

Option Care Health Trading Down 6.9 %

OPCH opened at $30.69 on Wednesday. The business has a fifty day moving average price of $33.34 and a 200 day moving average price of $28.79. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. Option Care Health has a 12 month low of $21.39 and a 12 month high of $35.53. The stock has a market capitalization of $5.04 billion, a price-to-earnings ratio of 25.79, a PEG ratio of 2.30 and a beta of 1.07.

Insider Buying and Selling at Option Care Health

In other news, insider Michael Bavaro sold 30,996 shares of the firm’s stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. This trade represents a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 0.64% of the stock is currently owned by insiders.

Institutional Trading of Option Care Health

A number of large investors have recently bought and sold shares of OPCH. Vanguard Group Inc. raised its holdings in shares of Option Care Health by 0.4% in the fourth quarter. Vanguard Group Inc. now owns 19,315,421 shares of the company’s stock valued at $448,118,000 after buying an additional 75,313 shares during the last quarter. Wellington Management Group LLP increased its position in Option Care Health by 84.6% in the 4th quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company’s stock valued at $425,143,000 after acquiring an additional 8,400,208 shares during the period. Dimensional Fund Advisors LP raised its stake in Option Care Health by 17.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company’s stock valued at $92,518,000 after acquiring an additional 591,042 shares during the last quarter. Northern Trust Corp lifted its position in Option Care Health by 11.8% during the 4th quarter. Northern Trust Corp now owns 2,626,478 shares of the company’s stock worth $60,934,000 after acquiring an additional 278,158 shares during the period. Finally, Norges Bank purchased a new position in shares of Option Care Health in the 4th quarter valued at approximately $60,219,000. Institutional investors and hedge funds own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.